#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Duchenne muscular dystrophy Cluster headache Scedosporium infection Hypersensitivity pneumonitis Aplastic anaemia Candida infection Neovascular age-related macular degeneration Liposarcoma recurrent Bile acid synthesis disorder Juvenile idiopathic arthritis Burkitt's lymphoma refractory Adenovirus infection Alternating hemiplegia of childhood Myelodysplastic syndrome with excess blasts Multiple system atrophy More trials…

    Learn about Rare Diseases

    Prader-Willi syndrome – Life with Disease MELAS syndrome Lymphangiosarcoma Familial haemophagocytic lymphohistiocytosis – Treatment Pleural mesothelioma malignant – Life with Disease Rosai-Dorfman syndrome – Diagnostics Rhabdoid tumour Bronchopulmonary dysplasia – Diagnostics Sarcoma – Treatment Immunodeficiency congenital – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    AGALSIDASE BETA Methoxyflurane Elezanumab Teverelix RO7284755 Polatuzumab Vedotin Niraparib Lidocaine Cls12311 Acetylcholine Chloride Isoflurane Oxybuprocaine Hydrochloride Opelconazole MB-HUCART19.1 Atidarsagene Autotemcel Thiamine Hydrochloride OMECAMTIV MECARBIL Human Serum Albumin CICLOPIROX THEOPHYLLINE ANHYDROUS More therapies…

    Learn about Your Condition

    Angiosarcoma recurrent Malformation venous Psoriatic arthropathy Haemofiltration C3 glomerulopathy Acromegaly Alveolar rhabdomyosarcoma Dystonia Colorectal cancer stage III Deafness Glucose tolerance impaired Nephropathy Hypoxia Exudative retinopathy Hypertriglyceridaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Immune Modulation Study of Rilvegostomig and Pembrolizumab in Patients with Advanced Gastric Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Rilvegostomig
    • Pembrolizumab
    Spain

  • A Phase 3 Study of Delgocitinib Cream to Evaluate Efficacy and Safety in Adult Women with Lichen Sclerosus

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Lichen sclerosus
    France Germany Italy Poland Spain

  • Capecitabine drug combination in perioperative treatment for patients with gastric and esophageal cancer

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Gastric cancer
    • Oesophageal carcinoma
    Investigated Drugs:
    • Capecitabine
    The Netherlands

  • Phase 2 Randomized Study of Mivelsiran in Adults with Early-Stage Down Syndrome-Associated Alzheimer’s Disease

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • ALN-961583
    • Water For Injection
    Germany Ireland Italy The Netherlands Spain

  • Colchicine for Reducing Dependency and Vascular Events in Patients After Acute Intracerebral Hemorrhage

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Colchicine
    Belgium Spain

  • Evaluation of belantamab mafodotin plus drug combination in adult patients with newly diagnosed light chain amyloidosis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Amyloidosis
    Investigated Drugs:
    • GSK5764227
    • Bortezomib
    • Cyclophosphamide
    Greece Italy Spain
Previous Page
1 … 674 675 676 677 678 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!